• Array


HypoPet has established a high-quality pipeline filled with promising new animal drug candidates that address major unmet needs in veterinary medicine. The platform vaccine technology can leverage the experience of monoclonal antibodies which have already achieved proof of principle (efficacy, safety & commercial) in humans and in some cases in companion animals. Our scientists and network of scientific and veterinary collaborators contribute to our target selection and development focus.

Find our Pipeline overview here